CUVITRU normal immunoglobulin (human) infusion 20% for subcutaneous use in glass vial Австралія - англійська - Department of Health (Therapeutic Goods Administration)

cuvitru normal immunoglobulin (human) infusion 20% for subcutaneous use in glass vial

takeda pharmaceuticals australia pty ltd - normal immunoglobulin, quantity: 1 g - solution - excipient ingredients: glycine; water for injections - cuvitru is indicated as replacement therapy in adult and paediatric patients for,? primary immunodeficiency diseases (pid) and,? symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.

FLEBOGAMMA 10% DIF normal immunoglobulin (Human) intravenous use injection vial Австралія - англійська - Department of Health (Therapeutic Goods Administration)

flebogamma 10% dif normal immunoglobulin (human) intravenous use injection vial

grifols australia pty ltd - normal immunoglobulin, quantity: 5 g - injection, solution - excipient ingredients: sorbitol; human immunoglobulin a; water for injections - replacement therapy indications: - primary immunodeficiency (pi) diseases - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.,immunomodulation indications: - idiopathic thrombocytopaenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count. - guillain barr? syndrome - kawasaki disease.

FLEBOGAMMA 10% DIF normal immunoglobulin (Human) 20g/200mL intravenous use injection vial Австралія - англійська - Department of Health (Therapeutic Goods Administration)

flebogamma 10% dif normal immunoglobulin (human) 20g/200ml intravenous use injection vial

grifols australia pty ltd - normal immunoglobulin, quantity: 20 g - injection, solution - excipient ingredients: human immunoglobulin a; water for injections; sorbitol - replacement therapy indications: - primary immunodeficiency (pi) diseases - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.,immunomodulation indications: - idiopathic thrombocytopaenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count. - guillain barr? syndrome - kawasaki disease.

FLEBOGAMMA 10% DIF normal immunoglobulin (Human) 10g/100mL intravenous use injection vial Австралія - англійська - Department of Health (Therapeutic Goods Administration)

flebogamma 10% dif normal immunoglobulin (human) 10g/100ml intravenous use injection vial

grifols australia pty ltd - normal immunoglobulin, quantity: 10 g - injection, solution - excipient ingredients: human immunoglobulin a; water for injections; sorbitol - replacement therapy indications: - primary immunodeficiency (pi) diseases - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.,immunomodulation indications: - idiopathic thrombocytopaenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count. - guillain barr? syndrome - kawasaki disease.

CSL CMV IMMUNOGLOBULIN VF (human) 1.5 million units/vial injection Австралія - англійська - Department of Health (Therapeutic Goods Administration)

csl cmv immunoglobulin vf (human) 1.5 million units/vial injection

csl behring australia pty ltd - human immunoglobulin g, quantity: 50 mg/ml; cytomegalovirus immunoglobulin, quantity: 1500000 u - injection, intravenous infusion - excipient ingredients: water for injections; human immunoglobulin a; maltose - cmv immunoglobulin-vf is indicated for the prevention of cmv infection following bone marrow and renal transplants. specifically, the product is indicated when the recipient is seronegative for cmv and receives a graft from a cmv positive donor. cmv immunoglobulin-vf may also be a helpful adjunct to therapy in patients with established cmv infection, e.g. cmv pneumonitis.

Hepacaf 5 000 IU inf. sol. (pwdr. + solv.) i.v. Бельгія - англійська - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

hepacaf 5 000 iu inf. sol. (pwdr. + solv.) i.v.

lfb biomedicaments s.a. - human hepatitis b immunoglobulin 5000 iu/100 ml - powder and solvent for solution for infusion - 5000 iu - human anti-hepatitis b immunoglobulin 5000 iu - hepatitis b immunoglobulin

Neohepatect 50 IU/ml inf. sol. i.v. vial Бельгія - англійська - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

neohepatect 50 iu/ml inf. sol. i.v. vial

biotest pharma gmbh - human hepatitis b immunoglobulin 50 iu/ml - solution for infusion - 50 iu/ml - human anti-hepatitis b immunoglobulin - hepatitis b immunoglobulin

Neohepatect 50 IU/ml inf. sol. i.v. vial Бельгія - англійська - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

neohepatect 50 iu/ml inf. sol. i.v. vial

biotest pharma gmbh - human hepatitis b immunoglobulin 50 iu/ml - solution for infusion - 50 iu/ml - human anti-hepatitis b immunoglobulin - hepatitis b immunoglobulin

Neohepatect 50 IU/ml inf. sol. i.v. vial Бельгія - англійська - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

neohepatect 50 iu/ml inf. sol. i.v. vial

biotest pharma gmbh - human hepatitis b immunoglobulin 50 iu/ml - solution for infusion - 50 iu/ml - human anti-hepatitis b immunoglobulin - hepatitis b immunoglobulin

Neohepatect 50 IU/ml inf. sol. i.v. vial Бельгія - англійська - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

neohepatect 50 iu/ml inf. sol. i.v. vial

biotest pharma gmbh - human hepatitis b immunoglobulin 50 iu/ml - solution for infusion - 50 iu/ml - human anti-hepatitis b immunoglobulin - hepatitis b immunoglobulin